TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30299178

Group type: EXPERIMENTAL
Intervention: Ginger root (1.425 g/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 29809257

Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Therapy (OMTh)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Muscle Stretching
Number of subjects: 12

Group type: COMPARATOR
Intervention: Soft Touch (Sham Intervention)
Number of subjects: 12
Study: 27090850

Group type: EXPERIMENTAL
Intervention: Live music therapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Recorded mindfulness exercise
Number of subjects: 84
Study: 24756128

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) (≥180 seconds after delivery)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Early cord clamping (ECC) (≤10 seconds after delivery)
Number of subjects: 382
Study: 22941041

Group type: EXPERIMENTAL
Intervention: Guided group attending intervention meetings with education on diet, exercise, AI culture, and emotional wellbeing
Number of subjects: 200

Group type: COMPARATOR
Intervention: Self-managed group receiving printed CVD prevention materials
Number of subjects: 200
Study: 21112429

Group type: EXPERIMENTAL
Intervention: Isometric strength measurements in neck and trunk region (flexion, extension, lateral flexion); measured over 2 examination days with 2 measurement passes.
Number of subjects: 95
Study: 18172036

Group type: EXPERIMENTAL
Intervention: Electronic alerts
Number of subjects: 87886

Group type: EXPERIMENTAL
Intervention: On-demand decision support
Number of subjects: 87886

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 87886
Study: 15701612

Group type: EXPERIMENTAL
Intervention: Betamethasone (4 mL of 2% xylocaine and 1 mL (6 mg) of betamethasone)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Xylocaine (5 mL of 2% xylocaine alone)
Number of subjects: 58
Study: 12928997

Group type: EXPERIMENTAL
Intervention: Kyphoplasty
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 22
Study: 10847423

Group type: EXPERIMENTAL
Intervention: 0.5 g/kg alcohol in orange-flavoured drink
Number of subjects: 11

Group type: COMPARATOR
Intervention: Non-caloric non-alcoholic drink
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both alcohol and control trials during exercise
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Alcohol ingestion
Number of subjects: 11
Study: 8925753

Group type: EXPERIMENTAL
Intervention: AVE micro-stent implantation with dual antiaggregation treatment (500 mg ticlopidine and 100 mg aspirin daily for 6 weeks)
Number of subjects: 121
Study: 7709692

Group type: EXPERIMENTAL
Intervention: human follicular fluid (hFF) treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: mini‐CDPG treatment
Number of subjects: 26
Study: 3110264

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 39
Study: 31790910

Group type: EXPERIMENTAL
Intervention: Psychological empowerment
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Meaning component of psychological empowerment
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Self-determination component of psychological empowerment
Number of subjects: 200
Study: 29673355

Group type: EXPERIMENTAL
Intervention: Mirabegron (25 mg for 4 weeks, then 50 mg for 4 weeks)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Tolterodine ER (4 mg for 8 weeks)
Number of subjects: 358
Study: 26921934

Group type: EXPERIMENTAL
Intervention: Multicomponent non‐pharmacologic intervention (orientation, sensorial deficit, sleep, mobilization, hydration, nutrition, drug chart review, elimination, oxygenation, pain)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care (Control Group)
Number of subjects: 50
Study: 26143942

Group type: EXPERIMENTAL
Intervention: IV lorazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: IV diazepam
Number of subjects: 0
Study: 23545834

Group type: EXPERIMENTAL
Intervention: GnRH-antagonist protocol with highly purified uFSH (Bravelle®) 300 IU/day and 0.25 mg/day GnRH-antagonist starting on cycle day 19-21
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional GnRH-antagonist protocol with 150-225 rFSH or HP-HMG/day
Number of subjects: 10
Study: 21303564

Group type: EXPERIMENTAL
Intervention: Health coaching (telephone and face-to-face) over 18 months in addition to usual care
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1320
Study: 19849683

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 99

Group type: COMPARATOR
Intervention: Facemask and oropharyngeal airway
Number of subjects: 99
Study: 18046928

Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future observational studies (PREDICTIVE and IMPROVE)
Number of subjects: 0
Study: 14978288

Group type: EXPERIMENTAL
Intervention: Increased cardiovascular fitness (highly fit individuals in Study 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aerobic training (aerobically trained individuals in Study 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low fitness (low-fit individuals in Study 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonaerobic control (nonaerobic control participants in Study 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased cardiovascular fitness (both studies)
Number of subjects: 0
Study: 11681652

Group type: EXPERIMENTAL
Intervention: Water-soluble sodium pertechnetate
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Water-insoluble tetraphenylarsonium pertechnetate
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 2
Study: 10653877

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus cisplatin (135 mg/m² and 250 mg/m²)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Etoposide plus cisplatin (100 mg/m² daily on days 1 to 3, with cisplatin 75 mg/m²)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Paclitaxel (all patients)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Etoposide plus cisplatin (stage IIIB)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Paclitaxel (stage IV)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Etoposide plus cisplatin (stage IV)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Quality of life (QOL)
Number of subjects: 599
Study: 7716219

Group type: EXPERIMENTAL
Intervention: SPE croissants (1.80 MJ)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: High-fat croissants (3.45 MJ)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Deprivation condition (0.25 h, 2.25 h, 4.75 h)
Number of subjects: 34
Study: 2715549

Group type: EXPERIMENTAL
Intervention: Peanut allergy (DBPCFC positive)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Accidental peanut ingestion
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Avoidance of peanut
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Reactions to other legumes and nonlegume nuts
Number of subjects: 32
Study: 1085599

Group type: EXPERIMENTAL
Intervention: Selective proximal vagotomy (SPV) without pyloroplasty
Number of subjects: 41
Study: 29587582

Group type: EXPERIMENTAL
Intervention: Upfront spironolactone 25 mg OD
Number of subjects: 80

Group type: COMPARATOR
Intervention: Discharge spironolactone 25 mg OD
Number of subjects: 80
Study: 28532864

Group type: EXPERIMENTAL
Intervention: Motion palpation tests (Sitting flexion, Standing flexion, Prone knee flexion, Gillet test)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pain provocation tests (FABER, Posterior shear, Resisted abduction test)
Number of subjects: 50
Study: 25697852

Group type: EXPERIMENTAL
Intervention: Gene Expression Profiling (GEP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Endomyocardial Biopsy (EMB)
Number of subjects: 60
Study: 23791320

Group type: EXPERIMENTAL
Intervention: Wrist support splinting and education for 8 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no intervention details provided)
Number of subjects: 54
Study: 20795383

Group type: EXPERIMENTAL
Intervention: Immunovac vaccine with basic therapy
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group with basic therapy only
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Immunovac vaccine
Number of subjects: 95
Study: 18421050

Group type: EXPERIMENTAL
Intervention: Anthracycline (alone or in combination)
Number of subjects: 3953
Study: 16649880

Group type: EXPERIMENTAL
Intervention: Strong African American Families Program (7-week family skills training program)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 332
Study: 12628865

Group type: EXPERIMENTAL
Intervention: Watch PAT100 (WP100) device
Number of subjects: 102

Group type: COMPARATOR
Intervention: In-laboratory polysomnography
Number of subjects: 102
Study: 10823095

Group type: EXPERIMENTAL
Intervention: Amethocaine patch
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ametop gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: COMPARATOR
Intervention: Amethocaine patch vs Ametop gel
Number of subjects: 30
Study: 2105795

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sinus rhythm group
Number of subjects: 100
Study: 7001667

Group type: EXPERIMENTAL
Intervention: Rigorous anti-mite measures
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (no anti-mite measures)
Number of subjects: 53
Study: 30459073

Group type: EXPERIMENTAL
Intervention: Intervention group (egg white replacement)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no dietary change)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study: 28463028

Group type: EXPERIMENTAL
Intervention: 10 ml 1% lidocaine paracervical block
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 400 µg oral misoprostol
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Oral naproxen
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 200
Study: 27565425

Group type: EXPERIMENTAL
Intervention: C‐Mill therapy (therapy with augmented reality)
Number of subjects: 40

Group type: COMPARATOR
Intervention: FALLS program (a conventional therapy program)
Number of subjects: 40
Study: 24661312

Group type: EXPERIMENTAL
Intervention: iQuit system (tailored printed and SMS text message self-help)
Number of subjects: 602

Group type: COMPARATOR
Intervention: usual care (control)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: iQuit system
Number of subjects: 602
Study: 21798108

Group type: EXPERIMENTAL
Intervention: OROS-MPH
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 19282706

Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block (CFNB)
Number of subjects: 50
Study: 17990227

Group type: EXPERIMENTAL
Intervention: Intrarectal quinine
Number of subjects: 110

Group type: COMPARATOR
Intervention: Intravenous quinine
Number of subjects: 110
Study: 16255339

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion (5 mEq/kg over 1 hour, followed by 5‐6 mEq/kg daily until recovery or death)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (standard treatment without high doses of sodium bicarbonate)
Number of subjects: 53
Study: 12067873

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (100 microgram) with hydromorphone (300 microgram)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Epidural fentanyl (100 microgram) with saline
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study: 9857617

Group type: EXPERIMENTAL
Intervention: Rotavirus infection
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Mixed bacterial-viral infections
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Enteropathogenic E. coli (EPEC)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: S. enteritidis
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: S. sonnei and E. coli 0127
Number of subjects: 169
Study: 7612060

Group type: EXPERIMENTAL
Intervention: 150 mg ranitidine bid
Number of subjects: 32

Group type: COMPARATOR
Intervention: 600 mg ibuprofen racemate tid + placebo
Number of subjects: 32
Study: 2503017

Group type: EXPERIMENTAL
Intervention: Digoxin withdrawal
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Digoxin reintroduction
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Digoxin treatment
Number of subjects: 44

Group type: COMPARATOR
Intervention: No deterioration
Number of subjects: 44
Study: 7266950

Group type: EXPERIMENTAL
Intervention: Intravenous ritodrine in a 0.1 wt/vol% solution of isotonic saline (N = 12)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Intravenous ritodrine in isotonic glucose (N = 11)
Number of subjects: 23
Study: 31350987

Group type: EXPERIMENTAL
Intervention: NAC + Vitamin A
Number of subjects: 30

Group type: COMPARATOR
Intervention: NAC
Number of subjects: 30
Study: 28292361

Group type: EXPERIMENTAL
Intervention: Per rectal misoprostol (800 µgm)
Number of subjects: 1678

Group type: COMPARATOR
Intervention: Intramuscular oxytocin (10 units)
Number of subjects: 1678
Study: 27187092

Group type: EXPERIMENTAL
Intervention: Resistance-based exercise
Number of subjects: 41

Group type: COMPARATOR
Intervention: Aerobic-based exercise
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both exercise groups
Number of subjects: 41
Study: 23249643

Group type: EXPERIMENTAL
Intervention: Extra-intervention group (with additional self-efficacy coaching)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Standard-intervention group (without additional self-efficacy coaching)
Number of subjects: 227
Study: 22743136

Group type: EXPERIMENTAL
Intervention: Light path coupled with tele-assistance service
Number of subjects: 194

Group type: COMPARATOR
Intervention: Unexposed group (no intervention)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Exposed group (intervention)
Number of subjects: 194
Study: 20187995

Group type: EXPERIMENTAL
Intervention: Pear-carrot-sea buckthorn (PCS) shots containing JA inulin (5 g/d)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Plum-pear-beetroot (PPB) shots containing JA inulin (5 g/d)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Pear-carrot-sea buckthorn (PCS) shots
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Plum-pear-beetroot (PPB) shots
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 18550472

Group type: EXPERIMENTAL
Intervention: HPV-16 detection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Biopsy diagnoses by clinical center (CC) pathologists
Number of subjects: 0
Study: 16555496

Group type: EXPERIMENTAL
Intervention: Irbesartan 150mg od
Number of subjects: 1963

Group type: EXPERIMENTAL
Intervention: Irbesartan 300mg od
Number of subjects: 1963
Study: 12500511

Group type: EXPERIMENTAL
Intervention: Intravenous lignocaine 1.5 mg/kg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Intravenous saline 0.075 ml/kg (control)
Number of subjects: 25
Study: 10036953

Group type: EXPERIMENTAL
Intervention: Lansoprazole (LPZ) 30 mg, Clarithromycin (CAM) 400 mg, Metronidazole (MTZ) 500 mg (LCM group)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ranitidine (RNT) 300 mg, Clarithromycin (CAM) 400 mg, Metronidazole (MTZ) 500 mg (RCM group)
Number of subjects: 99
Study: 8775019

Group type: EXPERIMENTAL
Intervention: Manual high‐velocity, low‐amplitude rotatory manipulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 60
Study: 2257961

Group type: EXPERIMENTAL
Intervention: 2% butoconazole nitrate cream used for 3 days
Number of subjects: 63

Group type: COMPARATOR
Intervention: 1% econazole nitrate cream used for 7 days
Number of subjects: 63
Study: 7066167

Group type: EXPERIMENTAL
Intervention: Meladinine tablets (Basotherm)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oxsoralen capsules (Elder)
Number of subjects: 8
Study: 30431298

Group type: EXPERIMENTAL
Intervention: Light therapy for 3 weeks
Number of subjects: 63

Group type: COMPARATOR
Intervention: Good sleeping adolescents (control group)
Number of subjects: 63
Study: 27854139

Group type: EXPERIMENTAL
Intervention: Handheld spectral domain optical coherence tomography (SDOCT) imaging
Number of subjects: 32

Group type: COMPARATOR
Intervention: Presence of ROP
Number of subjects: 32
Study: 26351345

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy with concurrent radiation therapy (RT)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Preoperative chemotherapy alone (without RT)
Number of subjects: 303
Study: 23820228

Group type: EXPERIMENTAL
Intervention: 80-μm flap LASIK
Number of subjects: 36

Group type: COMPARATOR
Intervention: 120-μm flap LASIK
Number of subjects: 36
Study: 21083673

Group type: EXPERIMENTAL
Intervention: 40 mg of esomeprazole twice daily for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 40
Study: 19120736

Group type: EXPERIMENTAL
Intervention: Nursing intervention via telephone follow-up
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Nursing intervention via telephone follow-up with advice
Number of subjects: 568

Group type: COMPARATOR
Intervention: Control group (no telephone follow-up)
Number of subjects: 568
Study: 17210397

Group type: EXPERIMENTAL
Intervention: T3-T4 sympathectomy
Number of subjects: 62

Group type: COMPARATOR
Intervention: T4 sympathectomy
Number of subjects: 62
Study: 15107193

Group type: EXPERIMENTAL
Intervention: Sulpiride 400 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lisuride 0.2 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11172176

Group type: EXPERIMENTAL
Intervention: Heptavalent pneumococcal polysaccharide conjugate vaccine
Number of subjects: 1662

Group type: COMPARATOR
Intervention: Hepatitis B vaccine
Number of subjects: 1662
Study: 9629950

Group type: EXPERIMENTAL
Intervention: Citalopram infusion (40 mg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Citalopram oral tablets (40 mg/day)
Number of subjects: 60
Study: 7827711

Group type: EXPERIMENTAL
Intervention: RC pulse (65% tilt monophasic waveform, 120 mu F capacitor)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: LRC pulse (damped sine wave, 40 mu F capacitor, 37-mH inductor)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Comparison of both waveforms
Number of subjects: 21
Study: 3262318

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 158

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 158
Study: 31608532

Group type: EXPERIMENTAL
Intervention: Rikkunshito (2.5 g t.i.d. for 4 weeks)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (matching placebo for 4 weeks)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Rikkunshito
Number of subjects: 23
Study: 30246183

Group type: EXPERIMENTAL
Intervention: 5 mm long implants
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 11.5 mm long implants
Number of subjects: 60

Group type: COMPARATOR
Intervention: Short implants (5 mm)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Long implants (11.5 mm)
Number of subjects: 60
Study: 28860264

Group type: EXPERIMENTAL
Intervention: Adaptive servo ventilation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 26588217

Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted thoracic paravertebral block with propofol general anesthesia (PPA group)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Fentanyl with sevoflurane general anesthesia (GA group)
Number of subjects: 247
Study: 24349149

Group type: EXPERIMENTAL
Intervention: Remote SDV
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traditional on-site SDV
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Remote SDV (Adult)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traditional on-site SDV (Adult)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Remote SDV (Pediatric)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traditional on-site SDV (Pediatric)
Number of subjects: 32
Study: 21147907

Group type: EXPERIMENTAL
Intervention: 5-day zinc treatment
Number of subjects: 1622

Group type: EXPERIMENTAL
Intervention: 10-day zinc treatment
Number of subjects: 1622
Study: 18418313

Group type: EXPERIMENTAL
Intervention: Iodinated contrast media (various types including high osmolal, low osmolal, and iso-osmolal)
Number of subjects: 0
Study: 15838437

Group type: EXPERIMENTAL
Intervention: Photoscreening
Number of subjects: 605

Group type: COMPARATOR
Intervention: Traditional screening
Number of subjects: 605
Study: 12718838

Group type: EXPERIMENTAL
Intervention: Combined DTPw‐HBV/Hib vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Separate DTPw‐HBV and Hib vaccines
Number of subjects: 0
Study: 10484257

Group type: EXPERIMENTAL
Intervention: Nurse case management
Number of subjects: 427

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 427
Study: 8966350

Group type: EXPERIMENTAL
Intervention: Double Burst Stimulus (DBS)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Train-of-Four (TOF)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Neostigmine
Number of subjects: 57
Study: 1864478

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 64

Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sodium Valproate
Number of subjects: 64
Study: 6628794

Group type: EXPERIMENTAL
Intervention: 5% benzoyl peroxide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Vehicle alone
Number of subjects: 24
Study: 31542145

Group type: EXPERIMENTAL
Intervention: Nicotine education (n=263)
Number of subjects: 521

Group type: COMPARATOR
Intervention: Sun safety education (attention control, n=128)
Number of subjects: 521

Group type: COMPARATOR
Intervention: No message control (n=130)
Number of subjects: 521
Study: 29408967

Group type: EXPERIMENTAL
Intervention: Combined CPVB+SGB (5mL and 3mL of levobupivacaine 0.5%)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Single CPVB (5mL of levobupivacaine 0.5%)
Number of subjects: 28
Study: 27130714

Group type: EXPERIMENTAL
Intervention: Broccoli sprouts (BS) 100 g daily for 3 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Alfalfa sprouts (AS) 100 g daily for 3 days (Control)
Number of subjects: 40
Study: 24587320

Group type: EXPERIMENTAL
Intervention: Active smoking of one cigarette
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (not smoking)
Number of subjects: 12
Study: 22712582

Group type: EXPERIMENTAL
Intervention: Intraprostatic injection of 200 U OnabotulinumtoxinA (BTX-A)
Number of subjects: 64